In_vivo_T-cell_activation_by_staphylococcal_enterotoxin_B_prevents_outgrowth_of_a_malignant_tumor._Treatment_of_T_cells_with_staphylococcal_enterotoxins_in_vitro_is_known_to_activate_T_cells_in_a_subset_restricted_manner_based_on_beta-chain_variable_region_(V_beta)_gene_expression._In_particular,_staphylococcal_enterotoxin_B_(SEB)_activates_T_cells_bearing_V_beta_7_or_V_beta_8._We_examined_the_ability_of_SEB_to_activate_T_cells_in_vivo._Treatment_of_C3H_mice_with_doses_of_SEB_ranging_from_5_to_250_micrograms_resulted_in_a_dose-dependent_activation_of_V_beta_8+_T_cells_as_reflected_by_increased_interleukin_2_receptor_(IL-2R)_expression,_proliferation_to_exogenous_IL-2_and_allogeneic_cells,_and_production_of_gamma_interferon._SEB_also_caused_proliferation_of_the_CD8+_subset_of_V_beta_8+_cells_in_vivo._Thus,_T-cell_activation_by_SEB_in_vivo_appears_to_be_specific_since_V_beta_2+_cells_(non-SEB_reactive)_did_not_show_increases_in_IL-2R_expression_similar_to_those_seen_with_V_beta_8+_cells_nor_did_they_proliferate._We_then_studied_the_ability_of_these_activated_cells_to_potentiate_the_immune_response_to_a_malignant_progressor_tumor._Treatment_of_C3H_mice_with_50_micrograms_of_SEB_at_the_time_of_inoculation_with_tumor_fragments_resulted_in_a_statistically_significant_decrease_in_the_frequency_of_tumor_outgrowth._These_data_demonstrate_that_treatment_of_C3H_mice_with_SEB_results_in_specific_activation_of_V_beta_8+_cells_in_vivo_and_that_these_activated_cells_are_capable_of_preventing_the_outgrowth_of_a_malignant_tumor.